The healthcare sector has been under a black cloud since the US Presidential Election last year, driven by concerns over drug pricing.
President Donald Trump's sharp criticism of the high cost of medicines in the US indicated he would take a tough stance against the industry. However, in recent weeks there have been reports that Trump...
Latest news and analysis
David Cumming, Aviva Investors' chief investment officer for equities, remains positive about UK stocks despite a pummelling in 2018
Equities overweight down to 3%
Relates to 136 million transaction reports
Patience must be a watchword